Szewczyk S, Buckley B, Chernov M, Wang X, Pathak S, Yeger H
Am J Cancer Res. 2024; 14(10):4772-4787.
PMID: 39553217
PMC: 11560832.
DOI: 10.62347/MBLD9480.
Arrasate A, Bravo I, Lopez-Robles C, Arbelaiz-Sarasola A, Ugalde M, Meijueiro M
Biomedicines. 2024; 12(10).
PMID: 39457578
PMC: 11504443.
DOI: 10.3390/biomedicines12102265.
Tridgett M, Mulet M, Johny S, Ababi M, Raghunath M, Fustinoni C
Mol Ther Methods Clin Dev. 2024; 32(3):101315.
PMID: 39282073
PMC: 11401174.
DOI: 10.1016/j.omtm.2024.101315.
Shah M, Krull A, ODonnell L, De Lima M, Bezerra E
Front Transplant. 2024; 2:1238535.
PMID: 38993860
PMC: 11235344.
DOI: 10.3389/frtra.2023.1238535.
Mier N, Roper D
PLoS One. 2024; 19(6):e0297817.
PMID: 38833479
PMC: 11149887.
DOI: 10.1371/journal.pone.0297817.
Development of KoRV-pseudotyped lentiviral vectors for efficient gene transfer into freshly isolated immune cells.
Renner A, Stahringer A, Ruppel K, Fricke S, Koehl U, Schmiedel D
Gene Ther. 2024; 31(7-8):378-390.
PMID: 38684788
PMC: 11257948.
DOI: 10.1038/s41434-024-00454-0.
Luciferase- and HaloTag-based reporter assays to measure small-molecule-induced degradation pathway in living cells.
Schwalm M, Saxena K, Muller S, Knapp S
Nat Protoc. 2024; 19(8):2317-2357.
PMID: 38637703
DOI: 10.1038/s41596-024-00979-z.
Manufacturing Cell and Gene Therapies: Challenges in Clinical Translation.
Lee N, Chang J
Ann Lab Med. 2024; 44(4):314-323.
PMID: 38361427
PMC: 10961620.
DOI: 10.3343/alm.2023.0382.
Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?.
Deng L, Liang P, Cui H
Genes Dis. 2023; 10(5):1937-1955.
PMID: 37492721
PMC: 10363566.
DOI: 10.1016/j.gendis.2022.03.007.
Serum-free lentiviral vector production is compatible with medium-resident nuclease activity arising from adherent HEK293T host cells engineered with a nuclease-encoding transgene.
Ali S, Rivera M, Ward J, Keshavarz-Moore E, Mason C, Nesbeth D
Heliyon. 2023; 9(6):e17067.
PMID: 37484388
PMC: 10361239.
DOI: 10.1016/j.heliyon.2023.e17067.
Process intensification for lentiviral vector manufacturing using tangential flow depth filtration.
Tona R, Shah R, Middaugh K, Steve J, Marques J, Roszell B
Mol Ther Methods Clin Dev. 2023; 29:93-107.
PMID: 36994313
PMC: 10041461.
DOI: 10.1016/j.omtm.2023.02.017.
Packaging cells for lentiviral vectors generated using the cumate and coumermycin gene induction systems and nanowell single-cell cloning.
Broussau S, Lytvyn V, Simoneau M, Guilbault C, Leclerc M, Nazemi-Moghaddam N
Mol Ther Methods Clin Dev. 2023; 29:40-57.
PMID: 36936448
PMC: 10018046.
DOI: 10.1016/j.omtm.2023.02.013.
Comparison of vector elements and process conditions in transient and stable suspension HEK293 platforms using SARS-CoV-2 receptor binding domain as a model protein.
Green E, Hamaker N, Lee K
BMC Biotechnol. 2023; 23(1):7.
PMID: 36882740
PMC: 9990576.
DOI: 10.1186/s12896-023-00777-7.
Efficient production of inhibitor-free foamy virus glycoprotein-containing retroviral vectors by proteoglycan-deficient packaging cells.
Munz C, Kreher H, Erdbeer A, Richter S, Westphal D, Yi B
Mol Ther Methods Clin Dev. 2022; 26:394-412.
PMID: 36034773
PMC: 9388887.
DOI: 10.1016/j.omtm.2022.07.004.
Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing.
Tran M, Kamen A
Front Bioeng Biotechnol. 2022; 10:887716.
PMID: 35774066
PMC: 9237754.
DOI: 10.3389/fbioe.2022.887716.
Targeted Locus Amplification as Marker Screening Approach to Detect Immunoglobulin (IG) Translocations in B-Cell Non-Hodgkin Lymphomas.
Genuardi E, Alessandria B, Civita A, Ferrero S
Methods Mol Biol. 2022; 2453:119-132.
PMID: 35622324
PMC: 9761915.
DOI: 10.1007/978-1-0716-2115-8_8.
Report on Webinar Series Cell and Gene Therapy: From Concept to Clinical Use.
van der Walle C, Dufes C, Desai A, Kerby J, Broadhead J, Tam A
Pharmaceutics. 2022; 14(1).
PMID: 35057063
PMC: 8778748.
DOI: 10.3390/pharmaceutics14010168.
HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors.
Tan E, Chin C, Lim Z, Ng S
Front Bioeng Biotechnol. 2021; 9:796991.
PMID: 34966729
PMC: 8711270.
DOI: 10.3389/fbioe.2021.796991.
Scalable Manufacturing of CAR T cells for Cancer Immunotherapy.
Abou-El-Enein M, Elsallab M, Feldman S, Fesnak A, Heslop H, Marks P
Blood Cancer Discov. 2021; 2(5):408-422.
PMID: 34568831
PMC: 8462122.
DOI: 10.1158/2643-3230.BCD-21-0084.
Lentiviral Vectors for T Cell Engineering: Clinical Applications, Bioprocessing and Future Perspectives.
Labbe R, Vessillier S, Rafiq Q
Viruses. 2021; 13(8).
PMID: 34452392
PMC: 8402758.
DOI: 10.3390/v13081528.